Co-Amplification of Chromosome 17 Genes Impacts HER2 Scoring

被引：0
|
作者：
Badve, Sunil [1 ]
Gokmen-Polar, Yesim [1 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
112
引用
收藏
页码：31A / 31A
页数：1
相关论文
共 50 条
  • [21] Utilization of Oligo-Array CGH To Determine HER2 Amplification Status, Amplicon Genomic Span, and Co-Amplification Signatures: Potential Complementary Role to HER2 FISH Testing
    Portier, B. P.
    Wang, Z.
    Lanigan, C.
    Batiouchko, G.
    Downs-Kelly, E.
    Richmond, T.
    Gerhardt, D.
    Munn, K.
    Haagmans, W.
    Tubbs, R.
    LABORATORY INVESTIGATION, 2012, 92 : 60A - 60A
  • [22] Increased co-amplification of HER2 and STARD3 in a cell line model of acquired lapatinib resistance
    McDermott, Martina
    Anderson, Lee
    Shields, Liam
    O'Brien, Neil
    Prendergast, Allison
    Kennedy, Susan
    Gallagher, William
    Zagozdzon, Radoslaw
    Byrne, Annette
    Crown, John
    Slamon, Dennis
    O'Donovan, Norma
    CANCER RESEARCH, 2013, 73 (08)
  • [23] Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry
    Davies, Vanessa
    Voutsadakis, Ioannis A.
    CANCER INVESTIGATION, 2020, 38 (02) : 94 - 101
  • [24] Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?
    Barden, J. M. S.
    Campbell, F. M.
    Mallon, E. A.
    CANCER RESEARCH, 2009, 69 (02) : 205S - 205S
  • [25] Determination of HER2 Amplification by In Situ Hybridization: When Should Chromosome 17 also be Determined?
    Bartlett, John M. S.
    Campbell, Fiona M.
    Mallon, Elizabeth A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (06) : 920 - 926
  • [26] HER2 Expression in Breast Cancer With Nonamplified HER2 and Gains of Chromosome 17 Centromere
    Panvichian, Ravat
    Tantiwetrueangdet, Anchalee
    Wongwaisayawan, Sansanee
    Nampoon, Amporn
    Lertsithichai, Panuwat
    Leelaudomlipi, Surasak
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (04) : 367 - 374
  • [27] Association of HER2/neu gene amplification and copy numbers of HER2/neu and chromosome 17 with tumor characteristics in resected colorectal cancer (CRC).
    Sharif, S
    Ramanathan, R
    Cieply, K
    Sasatomi, E
    Elinoff, B
    Liao, L
    Krasinskas, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 269S - 269S
  • [28] Chromosome 17 polysomy is common in breast cancer metastases and does not correlate with HER2/neu amplification or HER2/neu 2+staining by immunohistochemistry
    Varghese, L.
    Vanderwerf, S.
    Sweeney, C.
    Blair, C.
    Forster, C.
    Gulbahce, E.
    LABORATORY INVESTIGATION, 2007, 87 : 52A - 53A
  • [29] Chromosome 17 polysomy is common in breast cancer metastases and does not correlate with HER2/neu amplification or HER2/neu 2+staining by immunohistochemistry
    Varghese, L.
    Vanderwerf, S.
    Sweeney, C.
    Blair, C.
    Forster, C.
    Gulbahce, E.
    MODERN PATHOLOGY, 2007, 20 : 52A - 53A
  • [30] Her2/neu expression (IHC), amplification (FISH), and chromosome 17 aneuploidy in invasive lobular carcinoma
    Radhakrishnan, A
    Nassar, A
    Lewis, M
    Phillips, C
    Cohen, C
    LABORATORY INVESTIGATION, 2006, 86 : 40A - 40A
12345